flutamide has been researched along with angiotensinogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catterall, JF; Hardy, DO; Niu, EM | 1 |
| Bader, M; Baltatu, OC; Campos, LA; Cipolla-Neto, J; de Alencar Franco Costa, D; Todiras, M | 1 |
2 other study(ies) available for flutamide and angiotensinogen
| Article | Year |
|---|---|
Kap promoter analysis in vivo: a regulatory role for a truncated L1 repeat.
Topics: Angiotensinogen; Animals; Autoradiography; Castration; Dose-Response Relationship, Drug; Estradiol; Female; Flutamide; Gene Expression Regulation; Genes, Reporter; Humans; Kidney; Long Interspersed Nucleotide Elements; Male; Mice; Mice, Transgenic; Mutation; Promoter Regions, Genetic; Proteins; RNA, Messenger; Testosterone; Uterus | 2001 |
Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.
Topics: Albuminuria; Androgen Antagonists; Angiotensinogen; Animals; Biomarkers; Collagen Type I; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Fibronectins; Fibrosis; Flutamide; Kidney; Male; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Risk Factors; RNA, Messenger; Sex Factors | 2015 |